Redbud Labs

Chapel Hill, United States Founded: 2010 • Age: 16 yrs
Microfluidic platforms for biosensing and sample processing are manufactured.

About Redbud Labs

Redbud Labs is a company based in Chapel Hill (United States) founded in 2010. Redbud Labs has raised $305 thousand across 14 funding rounds from investors including HHS, VentureSouth and America’s Seed Fund. The company has 20 employees. Redbud Labs offers products and services including Redbud NA1, MXR, and STR. Redbud Labs operates in a competitive market with competitors including Lunaphore, Mekonos, Parallel Fluidics, CellFE and Lightcast Discovery, among others.

  • Headquarter Chapel Hill, United States
  • Employees 20
  • Sectors
    Healthcare
    Technology
  • Website redbudlabs.com
  • Social LinkedIn X
  • Legal Name Redbuds Labs, Inc.
Key Metrics
  • Total Equity Funding
    $305K (USD)

    in 14 rounds

  • Latest Funding Round
    $3.34M (USD), Grant

    Jun 2022

  • Investors
    HHS

    & 2 more

  • Employee Count
    20

Products & Services of Redbud Labs

Redbud Labs offers a comprehensive portfolio of products and services, including Redbud NA1, MXR, and STR.

Redbud NA1
Nucleic Acid Extraction Device

Automated system for reliable pathogen extractions in labs

MXR
Microfluidic System

Magnetic micro-posts for efficient microfluidic mixing applications

STR
Lab Tool

Technology for cell stirring in molecular processes

Funding Insights of Redbud Labs

Redbud Labs has successfully raised a total of $305K across 14 strategic funding rounds. The most recent funding activity was a Grant round of $3.34 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $304,995
  • Total Rounds 14
  • Last Round Grant — $3.34M
  • First Round $481,080

    (Jun 2012)

  • Investors Count 3

Latest 10 of 14 funding rounds of Redbud Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2022$3.34MGrant––
Jun 2021$1.29MGrant––
Jun 2021–Series A–VentureSouth
–
Jun 2020$4.86MGrant––
Jun 2019$2.5MGrant––
Dec 2018$304,995Seed––
–
Jun 2018$294,357Grant––
Jun 2017$2.29MGrant––
May 2017$215,000Debt – Conventional––
–
Apr 2017$1.32MGrant––
Valuation history

3 investors in total: 3 institutional.

Investors in Redbud Labs

Redbud Labs has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, VentureSouth and America’s Seed Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage ventures in the Southeast are supported by VentureSouth.
2014venturesouth.vcGreenville, United States
Venture capital fund backed by the US Government
–seedfund.nsf.govAlexandria, United States
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for Redbud Labs

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Redbud Labs

3 dated milestones of Redbud Labs across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Redbud Labs is founded.
  2. Funding First funding round of $481K.
  3. Funding Latest funding round, Grant, of $3.3M.

Competitors of Redbud Labs

Redbud Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lunaphore, Mekonos, Parallel Fluidics, CellFE and Lightcast Discovery, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lunaphore.com2014Morges, Switzerland$82.74M–
Microfluidic-based instruments for tumor analysis are developed.
mekonos.com2016Palo Alto, United States$29.6M–
Silicon-based nanomachine chips are developed for cell engineering applications.
parallelfluidics.com2020Boston, United States$13.97M–
Microfluidic chips are provided for research labs using embossing technology.
cellfebiotech.com2018Berkeley, United States$26.8M–
Intracellular gene delivery platform is developed using microfluidic devices.
lightcast.bio2019Cambridge, United Kingdom$107.09M25
Advanced single-cell analysis solutions are provided for biotechnology research.
sarcura.com2019Sankt Andra Wordern, Austria$10.24M–
Cell therapy solutions for multiple therapeutic areas are developed.
psidcorp.com2001Delray Beach, United States$10.88M–
Develops diagnostic tools for biological threats and healthcare using advanced PCR technology.
microxlabs.com2013Bengaluru, India$63,446–
MEMS-based biochips are developed for blood cell counting.
Premium access

Detailed competitors of Redbud Labs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Redbud Labs

Websites that share an audience with Redbud Labs (redbudlabs.com).

Similar websites

Websites whose visitors overlap most with Redbud Labs. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
trig.com
100%
4.6K#3,986,935View details

Latest news on Redbud Labs

Premium access

Complete news archive for Redbud Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Redbud Labs

10 companies that operate in the same segment as Redbud Labs (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Redbud Labs

Redbud Labs was founded in 2010 and raised its 1st funding round 2 years after it was founded.

Redbud Labs is headquartered in Chapel Hill, United States. It is registered at Chapel Hill, North Carolina, United States.

Redbud Labs is a funded company, having raised a total of $305K across 14 funding rounds to date. The company's 1st funding round was a Grant of $1.32M, raised on Jun 2012.

Redbud Labs has 20 employees.

Redbud Labs was founded in 2010 and is based in Chapel Hill, United States. Microfluidic platforms are produced for biosensing and sample processing within the biotechnology sector. Actuated surface-attached posts (ASAPs) are employed in these platforms, consisting of micro-posts that bend under magnetic fields to handle fluids, cells, and reagents. Operations focus on life science research tools and clinical diagnostics development, with applications in fluid manipulation at sub-bacterial scales.

Redbud Labs's top competitors include CellFE, Parallel Fluidics and Lightcast Discovery.

Redbud Labs offers Redbud NA1, MXR, and STR.

Redbud Labs has 3 investors. Key investors include HHS, VentureSouth, and America’s Seed Fund.

Redbud Labs operates through Redbuds Labs, Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available